Fertility Services Market by Service Type, End User, Fertility Treatment, Technology

List of Tables

The Fertility Services Market was valued at USD 43.93 billion in 2023, expected to reach USD 47.55 billion in 2024, and is projected to grow at a CAGR of 8.11%, to USD 75.84 billion by 2030.

Fertility services encompass a broad range of treatments aimed at aiding individuals and couples in achieving conception, covering procedures such as in vitro fertilization (IVF), intrauterine insemination (IUI), and other assisted reproductive technologies (ART). The necessity for these services stems from increasing infertility rates linked to lifestyle changes, delayed pregnancies, and rising awareness about reproductive health. Applications are predominantly medical, aiding those with infertility challenges, genetic conditions, or same-sex couples desiring parenthood. End-use segments include hospitals, fertility clinics, and surgical centers. The market is driven by technological advancements in ART, increasing public awareness, supportive government initiatives, and an aging population choosing to have children later in life. Emerging opportunities lie in personalized fertility treatments, improved cryopreservation techniques, and digital health solutions for monitoring reproductive health. To better capitalize on these, businesses should invest in R&D focused on enhancing IVF success rates and integrating AI for predictive diagnostics. However, the market faces limitations such as high procedural costs, limited insurance coverage, and ethical concerns surrounding ART. Additionally, regulatory challenges and socio-cultural taboos in certain regions continue to hinder market expansion. The growing demand for egg and sperm freezing among career-oriented individuals also indicates potential for growth. Innovations in non-invasive diagnostic tools and genetic screening could further extend the possibilities for treatment success and patient comfort. Market participation requires navigating these challenges while maintaining affordability and quality. The fertility services market is competitive and primarily driven by advancements in medical research, thus ongoing collaborations between biotech firms and healthcare providers could foster technological innovations and offer insights into consumer preferences, paving the way for business growth.

KEY MARKET STATISTICS
Base Year [2023]	USD 43.93 billion
Estimated Year [2024]	USD 47.55 billion
Forecast Year [2030]	USD 75.84 billion
CAGR (%)	8.11%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Fertility Services Market

The Fertility Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

Market Drivers
- Increasing prevalence of infertility issues and rising awareness about assisted reproductive technologies globally
- Government initiatives and supportive regulatory framework to improve fertility treatment accessibility
- Technological advancements in fertility treatments and diagnostics enhancing success rates
- High cost of advanced fertility treatments and limited reimbursement policies across various regions
Market Restraints
- Economic and regulatory challenges impacting the global fertility services market's reach and acceptance
- Technological and ethical dilemmas hindering the adoption of advanced fertility treatments
Market Opportunities
- Rising awareness and acceptance of male infertility issues driving market growth
- Increasing availability of affordable fertility treatments in emerging markets
- Expansion of fertility tourism due to cost-effective treatment options abroad
Market Challenges
- Stringent regulations in certain countries limiting the use of certain fertility treatments and technologies
- High cost of treatment of IVF and other ART procedures

Porter's Five Forces: A Strategic Tool for Navigating the Fertility Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Fertility Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Fertility Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Fertility Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Fertility Services Market

A detailed market share analysis in the Fertility Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Fertility Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Fertility Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Fertility Services Market

A strategic analysis of the Fertility Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Fertility Services Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspira Women's Health Inc., Celmatix Inc., Cook Medical Group, Inc., CooperSurgical, Inc., Ferring Pharmaceuticals, FUJIFILM Irvine Scientific, Inc., Genea Limited, Illumina, Inc., Irvine Scientific Sales Company, Inc., Kaiser Permanente, Mayo Clinic, Merck KGaA, Natera, Inc., Prelude Fertility, Inc., Progyny, Inc., Thermo Fisher Scientific Inc., and Vitrolife AB.

Market Segmentation & Coverage

This research report categorizes the Fertility Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

Based on Service Type, market is studied across Donor Egg IVF, IVF with ICSI, and Surrogacy. The Donor Egg IVF is further studied across Fresh Donor and Frozen Donor.
Based on End User, market is studied across Fertility Clinics, Hospitals, Research Institutes, and Surgical Centers.
Based on Fertility Treatment, market is studied across IUI, IVF, Medication, and Surgery.
Based on Technology, market is studied across Artificial Insemination, Frozen Embryo Transfer (FET), IVF ICSI, and Pre-Implantation Genetic Diagnosis (PGD).
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-535C62918B36

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of infertility issues and rising awareness about assisted reproductive technologies globally
  - 5.1.1.2. Government initiatives and supportive regulatory framework to improve fertility treatment accessibility
  - 5.1.1.3. Technological advancements in fertility treatments and diagnostics enhancing success rates
  - 5.1.1.4. High cost of advanced fertility treatments and limited reimbursement policies across various regions
- 5.1.2. Restraints
  - 5.1.2.1. Economic and regulatory challenges impacting the global fertility services market's reach and acceptance
  - 5.1.2.2. Technological and ethical dilemmas hindering the adoption of advanced fertility treatments
- 5.1.3. Opportunities
  - 5.1.3.1. Rising awareness and acceptance of male infertility issues driving market growth
  - 5.1.3.2. Increasing availability of affordable fertility treatments in emerging markets
  - 5.1.3.3. Expansion of fertility tourism due to cost-effective treatment options abroad
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations in certain countries limiting the use of certain fertility treatments and technologies
  - 5.1.4.2. High cost of treatment of IVF and other ART procedures
5.2. Market Segmentation Analysis
5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental

6. Fertility Services Market, by Service Type

6.1. Introduction
6.2. Donor Egg IVF
- 6.2.1. Fresh Donor
- 6.2.2. Frozen Donor
6.3. IVF with ICSI
6.4. Surrogacy

7. Fertility Services Market, by End User

7.1. Introduction
7.2. Fertility Clinics
7.3. Hospitals
7.4. Research Institutes
7.5. Surgical Centers

8. Fertility Services Market, by Fertility Treatment

8.1. Introduction
8.2. IUI
8.3. IVF
8.4. Medication
8.5. Surgery

9. Fertility Services Market, by Technology

9.1. Introduction
9.2. Artificial Insemination
9.3. Frozen Embryo Transfer (FET)
9.4. IVF ICSI
9.5. Pre-Implantation Genetic Diagnosis (PGD)

10. Americas Fertility Services Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Fertility Services Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Fertility Services Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

Companies Mentioned

1. AbbVie Inc.
2. Aspira Women's Health Inc.
3. Celmatix Inc.
4. Cook Medical Group, Inc.
5. CooperSurgical, Inc.
6. Ferring Pharmaceuticals
7. FUJIFILM Irvine Scientific, Inc.
8. Genea Limited
9. Illumina, Inc.
10. Irvine Scientific Sales Company, Inc.
11. Kaiser Permanente
12. Mayo Clinic
13. Merck KGaA
14. Natera, Inc.
15. Prelude Fertility, Inc.
16. Progyny, Inc.
17. Thermo Fisher Scientific Inc.
18. Vitrolife AB